RAND's Critical Technologies Institute, in cooperation with the American ChemicalSociety, is pleased to present an Emerging Technologies Seminar:

Thursday, April 23, 1998
8:00 - 9:30 AM

1333 H Street, NW
Suite 800
Washington, DC 20005
202-296-5000 x5685
cti@rand.org

Abstract:

The biotechnology and pharmaceuticals industries have shown an increasinglyrobust capability to create new technologies and new products. Although lifesciences have taken the lion's share of the credit, a significant portion of theadvances in the field stem from innovations in chemistry. In particular,combinatorial chemistry--a technology for mass producing molecules and testingthem rapidly against possible applications-has greatly accelerated the discoveryprocess in pharmaceuticals and chemicals. Chemical processes are also making anincreasing contribution to gene splicing and repair. Developments in chemistrymay be putting the biotechnology revolution on a new threshold of productivityand innovation. This seminar will explore these developments and the promisethey hold for contributing to the biotech field over the next 10 years.

Speakers:

Dr. Paul S. Anderson, Vice President, Chemical and Physical Sciences,Dupont/Merck Pharmaceuticals, Wilmington, Delaware, and Immediate Past President,American Chemical Society

Mr. Stephen Turner, Chairman, Oncor, Bethesda, Maryland

Continental Breakfast Served. Please RSVP:

Caroline S. Wagner
Critical Technologies Institute at RAND
Caroline_Wagner@rand.org